Type 1 Diabetes TrialNet

Fighting Diseases

Is Hydroxychloroquine Safe for Autoimmune Diseases?

COVID-19 has put a therapy called hydroxychloroquine in the spotlight — and, at the same time, shrouded it in confusion.

Community Stories

Meet the 10-Year-Old Who is Helping BRI Fight T1D Amid COVID-19

BRI Clinical Research Participant Zoey Brooke's in-person study visits may have been canceled due to the pandemic, but Zoey isn’t giving up.

Fighting Diseases

DCRP-2018

How BRI is Fighting Type 1 Diabetes

BRI researchers have spent more than two decades pursuing one of T1D research’s holy grails: a way to halt the disease before insulin production stops.

A simple blood test can identify five autoantibodies that signal an increased risk of type 1 diabetes (T1D).

Run and Get Screened for Type 1 Diabetes Research!

Did you know family members of people with type 1 diabetes (T1D) have a 15 times greater risk of developing the disease themselves?

As a person living with type 1 myself, I feel so much gratitude toward all of the research participants who allow for the development of diabetes care and technologies that permit me to live a full and healthy life.

Fighting Type 1 Diabetes: One Blood Draw at a Time

As a person living with type 1, I feel so much gratitude toward all of the research participants who have allowed for the development of diabetes care and technologies that permit me to live a full and healthy life!

Community Stories

Morris Family Supports Diabetes Community

Morris Family Commitment to Type 1 Diabetes Community

The Morris family was celebrating Christmas when they realized their nine-year-old son Jordan needed to go to the doctor.

New Leadership Role

Carla Greenbaum, MD, has been named chair of Type 1 Diabetes TrialNet.

Living With A Disease

Benaroya Research Institute

Joining Research to Prevent Type 1 Diabetes

A common myth about type 1 diabetes is that it skips generations.